|
|
|
|
LEADER |
00000cam a2200000 a 4500 |
001 |
SCIDIR_ocn268679683 |
003 |
OCoLC |
005 |
20231117015126.0 |
006 |
m o d |
007 |
cr cnu---unuuu |
008 |
081103s1982 nyua ob 001 0 eng d |
040 |
|
|
|a N$T
|b eng
|e pn
|c N$T
|d OCLCQ
|d IDEBK
|d E7B
|d OCLCQ
|d OPELS
|d OCLCQ
|d OCLCA
|d OCLCF
|d YDXCP
|d OCLCQ
|d UAB
|d OCLCQ
|d LEAUB
|d OCLCO
|d OCLCQ
|d OCLCA
|d INARC
|d VLY
|d OCLCA
|d OCLCO
|d OCLCQ
|d OCLCO
|
019 |
|
|
|a 646754743
|a 1162102417
|
020 |
|
|
|a 9780080581101
|q (electronic bk.)
|
020 |
|
|
|a 0080581102
|q (electronic bk.)
|
020 |
|
|
|a 0120329190
|q (electronic bk.)
|
020 |
|
|
|a 9780120329199
|q (electronic bk.)
|
020 |
|
|
|a 1281466573
|
020 |
|
|
|a 9781281466570
|
020 |
|
|
|a 9786611466572
|
020 |
|
|
|a 6611466576
|
035 |
|
|
|a (OCoLC)268679683
|z (OCoLC)646754743
|z (OCoLC)1162102417
|
050 |
|
4 |
|a RM300
|b .A38eb vol. 19
|
060 |
|
4 |
|a QV 5 A2442 v.19 1982
|
072 |
|
7 |
|a MED
|x 023000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 071000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 072000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 058170
|2 bisacsh
|
082 |
0 |
4 |
|a 615/.1
|2 22
|
245 |
0 |
0 |
|a Advances in pharmacology and chemotherapy.
|n Volume 19 /
|c edited by Silvio Garattini [and others] ; consulting editor, R.J. Schnitzer.
|
260 |
|
|
|a New York :
|b Academic Press,
|c 1982.
|
300 |
|
|
|a 1 online resource (x, 294 pages) :
|b illustrations
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
0 |
|
|a Advances in pharmacology and chemotherapy ;
|v v. 19
|
504 |
|
|
|a Includes bibliographical references and index.
|
588 |
0 |
|
|a Print version record.
|
505 |
0 |
|
|a Cover; Contents; Chapter 1. Chloroethylnitrosourea Cancer Chemotherapeutic Agents; I. Introduction; II. Development of New Chloroethylnitrosoureas; III. Chemistry; IV. Reactive Intermediates; V. Active Species; VI. Mechanism of Cytotoxicity; VII. Biodisposition; VIII. Chemicobiological Interactions; IX. Conclusion; References; Chapter 2. The Interaction of Cancer Chemotherapy Agents with Mononuclear Phagocytes; I. Introduction; II. Effects of Chemotherapeutic Agents on Mononuclear Phagocytes; III. Effects of Chemotherapeutic Agents on Tumor-Associated Macrophages (TAM)
|
505 |
8 |
|
|a IV. Antitumor Efficacy and Modulation of Mononuclear PhagocytesV. Concluding Remarks; References; Chapter 3. Mebendazole and Related Anthelmintics; I. Introduction; II. Chemistry and Pharmacology; III. Benzimidazole Carbamates in Veterinary Medicine; IV. Benzimidazole Carbamates in Human Medicine; V. Conclusion; References; Chapter 4. Chemotherapy of Human Intestinal Helminthiasis: A Review with Particular Reference to Community Treatment; I. Summary; II. Introduction; III. The Parasites; IV. The Human Host; V. The Drugs; VI. Therapeutic Intervention; References
|
505 |
8 |
|
|a Chapter 5. Development of Radiosensitizers: A Medicinal Chemistry PerspectiveI. Introduction; II. General Background; III. Structure Activity/Toxicity Determinants; IV. Medicinal Chemistry of Electron-Affinic Radiosensitizers; V. Summary and Perspectus for the Future; References; Chapter 6. The Effects of Antineoplastic Therapy on Growth and Development in Children; I. Introduction; II. Antineoplastic Therapy; III. Central Nervous System Toxicity; IV. Endocrine Organ Toxicity; V. Skeletal Growth; VI. Psychosocial Development; VII. Concluding Remarks; References
|
505 |
8 |
|
|a Chapter 7. Biological Properties of ICRF-159 and Related Bis(diox0piperazine) CompoundsI. Historical; II. Chemistry and Structure-Activity Relationships; III. Biological Characteristics; IV. Radiosensitization; V. Pharmacology; VI. Toxicology; VII. Clinical; VIII. Interactions of ICRF Compounds with Other Agents; IX. Prospective Views; References; Note Added in Proof; Index
|
520 |
|
|
|a ADV IN PHARMACOLOGY & CHEMOTHERAPY VOL 19.
|
546 |
|
|
|a English.
|
650 |
|
0 |
|a Pharmacology.
|
650 |
|
0 |
|a Chemotherapy.
|
650 |
|
2 |
|a Pharmacology
|0 (DNLM)D010600
|
650 |
|
2 |
|a Drug Therapy
|0 (DNLM)D004358
|
650 |
|
6 |
|a Pharmacologie.
|0 (CaQQLa)201-0007219
|
650 |
|
6 |
|a Chimioth�erapie.
|0 (CaQQLa)201-0034750
|
650 |
|
7 |
|a pharmacology.
|2 aat
|0 (CStmoGRI)aat300137970
|
650 |
|
7 |
|a MEDICAL
|x Drug Guides.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Pharmacy.
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL
|x Nursing
|x Pharmacology.
|2 bisacsh
|
650 |
|
7 |
|a Chemotherapy
|2 fast
|0 (OCoLC)fst00853595
|
650 |
|
7 |
|a Pharmacology
|2 fast
|0 (OCoLC)fst01060259
|
700 |
1 |
|
|a Garattini, Silvio.
|
700 |
1 |
|
|a Schnitzer, Robert J.
|q (Robert Julius),
|d 1894-
|
776 |
0 |
8 |
|i Print version:
|t Advances in pharmacology and chemotherapy. Volume 19.
|d New York : Academic Press, 1982
|z 9780120329199
|w (OCoLC)39619797
|
856 |
4 |
0 |
|u https://sciencedirect.uam.elogim.com/science/book/9780120329199
|z Texto completo
|